Review
Open access
Sep 2026
Ibalizumab: a comprehensive review of a pioneering monoclonal antibody therapy in the management of HIV/AIDS
Ibalizumab represents a genuine therapeutic advance for patients with MDR HIV-1 who have exhausted conventional regimens, and its unique mechanism, established efficacy, and favourable safety profile make it an indispensable salvage therapy component.
P. Ashinze, Suvam Banerjee, E. Akande et al.
· Exploration of Medicine · 0 citations